SpineGuard Announces the Revision of Its 2022 Financial Calendar
25 Mars 2022 - 06:00PM
Business Wire
Regulatory News:
SpineGuard (FR0011464452 – ALSGD) (Paris:ALSGD), an
innovative company that deploys its DSG (Dynamic Surgical Guidance)
sensing technology to secure and streamline the placement of bone
implants, announced today its revised schedule for the publication
of financial information for 2022.
Revised 2022 financial calendar
Event
Date*
2021 Full-Year Sales
January 26, 2022
2021 Full-Year Results
April 28, 2022 (vs. April 20,
202)
2022 First-Quarter Sales
April 28, 2022 (vs. April 20,
202)
Annual Shareholders Meeting
June 8, 2022
2022 First-Half Sales
July 12, 2022
2022 First-Half Results
September 14, 2022
2022 Third-Quarter Sales
October 12, 2022
Note (*): Press releases are published after stock market
closes. This information is subject to modification.
About SpineGuard® Founded in 2009 in France and the USA
by Pierre Jérôme and Stéphane Bette, SpineGuard is an innovative
company deploying its proprietary radiation-free real time sensing
technology DSG® (Dynamic Surgical Guidance) to secure and
streamline the placement of implants in the skeleton. SpineGuard
designs, develops and markets medical devices that have been used
in over 85,000 surgical procedures worldwide. Nineteen studies
published in peer-reviewed scientific journals have demonstrated
the multiple benefits DSG® offers to patients, surgeons, surgical
staff and hospitals. Building on these strong fundamentals and
several strategic partnerships, SpineGuard has expanded the scope
of its DSG® technology in innovative applications such as the «
smart » pedicle screw, the DSG Connect visualization and
registration interface, dental implantology and surgical robotics.
DSG® was co-invented by Maurice Bourlion, Ph.D., Ciaran Bolger,
M.D., Ph.D., and Alain Vanquaethem, Biomedical Engineer. SpineGuard
has engaged in multiple ESG initiatives.
For further information, visit www.spineguard.com
Disclaimer: The SpineGuard securities may not be offered
or sold in the United States as they have not been and will not be
registered under the Securities Act or any United States state
securities laws, and SpineGuard does not intend to make a public
offer of its securities in the United States. This is an
announcement and not a prospectus, and the information contained
herein does and shall not constitute an offer to sell or the
solicitation of an offer to buy, nor shall there be any sale of the
securities referred to herein in the United States in which such
offer, solicitation or sale would be unlawful prior to registration
or exemption from registration.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220325005165/en/
SpineGuard Pierre Jérôme CEO & Chairman Tel: +33 1 45
18 45 19 p.jerome@spineguard.com
SpineGuard Manuel Lanfossi CFO Tel: +33 1 45 18 45 19
m.lanfossi@spineguard.com
NewCap Investor Relations & Financial Communication
Mathilde Bohin / Pierre Laurent Tel.: +33 1 44 71 94 94
spineguard@newcap.eu
Spineguard (EU:ALSGD)
Graphique Historique de l'Action
De Fév 2024 à Mar 2024
Spineguard (EU:ALSGD)
Graphique Historique de l'Action
De Mar 2023 à Mar 2024